23andMe, named after the number of chromosome pairs in humans, is a consumer genetics and research company. Co-founded by Linda Avey and Anne Wojcicki, 23andMe has plans to make the human genome searchable. The company aims to help people understand what their genes mean by indexing the genes and highlighting significant findings. 23andMe allows its customers to study their ancestry, genealogy, and inherited traits by analyzing their DNA from saliva samples. The company also markets to researchers and scientists, for whom they provide categorized and searchable data.
How It Works
Live Long And Prosper: How Anne Wojcicki’s 23andMe Will Mine Its Giant DNA Database For Health And Wealth
Forbes - Jun 6, 2019
Airbnb Partners With 23andMe To Recommend Heritage Inspired Vacations
Forbes - Jun 5, 2019
23andMe and AirBnB:Is Cultural Identity A Market To Explore For Consumer Genetic-Testing Companies?
Forbes - Jun 1, 2019
Airbnb and 23andMe want you to take a “heritage vacation”
Fast Company - May 21, 2019
Why Sperm Donor Privacy Is Under Threat From DNA Sites — Is There Anything They Can Do About It?
Forbes - Apr 23, 2019
What Interesting Trends Are We Seeing In Genetics Research Right Now?
Forbes - Apr 5, 2019
23andMe’s Growth Slows
Wall Streets Journal - Feb 8, 2019
Health Catalyst Hits $1 Billion Valuation With Latest Financing
Wall Streets Journal - Feb 7, 2019
23andMe Responds: Empowering Consumers
New York Times - Feb 5, 2019
NY Times, Why Are You So Worried About 23andMe's Genetic Tests?
Forbes - Feb 4, 2019
23andMe updates its ancestry reports, but they’re still not perfect
TechCrunch - Jan 15, 2019
23andMe Deepens Push Into Health Care
Wall Streets Journal - Jan 8, 2019
Amazon Black Friday 2018: 23andMe DNA Test Gets A Steep Price Cut
Forbes - Nov 23, 2018
Sigrid Johnson Was Black. A DNA Test Said She Wasn't.
New York Times - Nov 19, 2018
Meet The Woman Behind 23andMe's Plan To Keep Your Data Safe
Forbes - Nov 6, 2018
23andMe CEO Wojcicki Says FDA Approval Is 'Huge Step Forward'
Bloomberg - Nov 5, 2018
23andMe's genetic test for how you'll react to medication is ahead of its time
The Verge - Nov 2, 2018
23andMe CEO Anne Wojcicki says 'one of our biggest competitors' is fake science on sites like Goop
Recode - Oct 20, 2018
23andMe underscores that privacy-loving customers need to opt out of its data deal with GlaxoSmithKline
TechCrunch - Sep 5, 2018
23andMe might soon offer a more comprehensive $749 DNA service
TechCrunch - Sep 5, 2018
23andMe’s ancestry tools are getting better for people of color
TechCrunch - Aug 21, 2018
Scoop: 23andMe is raising up to $300M
PitchBook News & Analysis - Jul 24, 2018
How To Grow And Scale A Culture Like 23andMe
Forbes - Jul 18, 2018
- Anne Wojcicki, Co-Founder and CEO
- Richard Scheller, PhD, Chief Science Officer
- Steve Schoch, Chief Financial Officer
- Kathy Hibbs, Chief Legal and Regulatory Officer
EquityZen does not have an affiliation with, formal relationship with, or endorsement from 23andMe or any companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.
EQUITYZEN and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.